PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study



Status:Completed
Conditions:Colorectal Cancer, Cancer, Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - Any
Updated:12/31/2017
Start Date:November 3, 2009
End Date:January 2, 2015

Use our guide to learn which trials are right for you!

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)

This is a phase 3, randomized, double-blind, placebo-controlled multi-center study evaluating
the efficacy of pegfilgrastim to reduce the incidence of febrile neutropenia (FN) in patients
with newly diagnosed, locally-advanced or metastatic colorectal cancer receiving first-line
treatment with bevacizumab and either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or
5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI).

This study will also investigate the effect of adding pegfilgrastim to bevacizumab and either
FOLFOX or FOLFIRI by evaluating overall survival, progression-free survival, and overall
response rate in each arm at regular intervals over a maximum of 60 months follow-up.


Inclusion Criteria:

Disease-related:

- Histologically or cytologically-confirmed adenocarcinoma of the colon or rectum

- Locally-advanced or metastatic disease by radiographic evaluation

- Measurable disease

- Has not previously received chemotherapy for locally-advanced or metastatic colorectal
cancer. Patient may have received adjuvant therapy for primary colorectal cancer
provided that at least 6 months have elapsed from the time the adjuvant therapy was
concluded and recurrent/metastatic disease was documented.

- Eastern Cooperative Oncology Group (ECOG) Performance status 0-2

Demographic:

- Age of 18 years or over

Laboratory:

Adequate organ and marrow function as defined below:

- Absolute neutrophil count at least 1.5 x 10^9/L

- Platelet count at least 100 x 10^9/L

- Bilirubin ≤ 1.5 times upper limit of normal

- Aspartate aminotransferase and alanine aminotransferase ≤ 2.5 x upper limit of normal
or Aspartate aminotransferase and alanine aminotransferase ≤ 5.0 x upper limit of
normal if attributable to liver metastasis

- An in-range international normalized ratio (INR) (in-range is usually defined as
between 2 and 3) for patients on a stable dose of oral anticoagulant or stable dose of
low molecular weight heparin

- Has no active bleeding or pathological condition that carries high risk of bleeding
(eg, tumor involving major vessels or known varices). If a suspicion of bleeding
diathesis exists, a bleeding time should be performed

- Creatinine ≤ 1.5 times upper limit of normal

General:

- Written informed consent obtained

- Afebrile on day 1 of cycle 1

- Must be able and willing to comply with study and/or follow-up procedures

Exclusion Criteria:

Disease-Related:

- Known brain metastases

- History of another primary malignancy less than/equal to 5 years prior to
randomization, with the exception of non-melanoma skin cancer, carcinoma in situ of
uterine cervix, and prostatic intraepithelial neoplasia without evidence of prostate
cancer

- Prior major surgical procedure less than 28 days prior to day 1 of cycle 1
chemotherapy dosing; anticipated need for major surgical procedure during the 4 cycle
treatment period of the study

- Fine needle aspirations or core biopsies within 7 days prior to day 1 of cycle 1
chemotherapy dosing

- Serious nonhealing wound, ulcer, or bone fracture, or history of abdominal fistula,
gastrointestinal perforation, or intra-abdominal abscess within 6 months prior to day
1 of cycle 1

- Uncontrolled high blood pressure, history of labile hypertension, uncontrolled
congestive heart failure, unstable angina within the past 3 months, myocardial
infarction or history of stroke within the past 12 months, unstable symptomatic
arrhythmia requiring medication, or clinically significant peripheral vascular disease

- History of clinically significant bleeding within 6 months prior to randomization

- History of arterial or venous thromboembolism within 6 months prior to randomization

- History of other disease including uncontrolled diabetes, serious active or
uncontrolled infection, metabolic dysfunction; physical examination finding, or
clinical laboratory finding giving reasonable suspicion of a disease or condition that
contraindicates the use of the prescribed therapy or that might affect the
interpretation of the results of the study or render the subject at high risk from
treatment complications

Laboratory:

- Proteinuria > 1+, or total quantitative protein > 500 mg protein/day as determined by
24-hr urine collection

Medications:

- Prior radiotherapy unless treatment was limited to the target lesion and only 1
measurable lesion was treated. Progression of the irradiated lesion must be
demonstrated. Patients may not have received prior radiotherapy to greater than 25% of
bone marrow. Radiation must have concluded ≥ 4 weeks prior to enrollment. Prior
radio-sensitizing chemoradiation will be allowed as long as it was concluded ≥ 4 weeks
prior to enrollment.

- Radiotherapy to non-target lesions for pain control will be allowed

- Prior bevacizumab use or other agents targeting VEGF

- Concurrent use of other biological agents

- Use of systemic anti-infectives for active infection, during the 3 calendar days
before starting study chemotherapy and bevacizumab or planned during the study
treatment period

General:

- Current, recent (within 4 weeks of the first infusion of this study), or planned
participation (during the study treatment period) in an experimental therapeutics
study other than this protocol

- Female participants who are pregnant or lactating or men and women of reproductive
potential not willing to employ an effective method of birth control during treatment
and for 20 weeks for women, and 30 weeks for men after discontinuing study treatment

- History of allergic reactions attributed to compounds of similar chemical or biologic
composition to bevacizumab, irinotecan, 5-fluorouracil (5-FU), oxaliplatin, or
leucovorin, including known sensitivity to E. Coli derived products (eg, Filgrastim,
HUMULIN insulin, L-asparaginase)

- Known dihydropyrimidine dehydrogenase deficiency
We found this trial at
70
sites
Portsmouth, New Hampshire 03801
2591
mi
from 91732
Portsmouth, NH
Click here to add this to my saved trials
2025
mi
from 91732
Abingdon, VA
Click here to add this to my saved trials
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
16
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Beverly Hills, California 90211
21
mi
from 91732
Beverly Hills, CA
Click here to add this to my saved trials
951
mi
from 91732
Billings, MT
Click here to add this to my saved trials
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
1282
mi
from 91732
Bryan, TX
Click here to add this to my saved trials
2044
mi
from 91732
Canton, OH
Click here to add this to my saved trials
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
1293
mi
from 91732
Corpus Christi, TX
Click here to add this to my saved trials
1303
mi
from 91732
Council Bluffs, IA
Click here to add this to my saved trials
2185
mi
from 91732
Cumberland, MD
Click here to add this to my saved trials
2360
mi
from 91732
Dover, DE
Click here to add this to my saved trials
2103
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
1174
mi
from 91732
Grand Island, NE
Click here to add this to my saved trials
2451
mi
from 91732
Greenwich, CT
Click here to add this to my saved trials
1720
mi
from 91732
Gurnee, IL
Click here to add this to my saved trials
1955
mi
from 91732
Hazard, KY
Click here to add this to my saved trials
2069
mi
from 91732
Hickory, NC
Click here to add this to my saved trials
2141
mi
from 91732
High Point, NC
Click here to add this to my saved trials
Hilton Head Island, South Carolina 29926
2148
mi
from 91732
Hilton Head Island, SC
Click here to add this to my saved trials
7980
mi
from 91732
Hobart,
Click here to add this to my saved trials
2573
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
1152
mi
from 91732
Hutchinson, KS
Click here to add this to my saved trials
1462
mi
from 91732
Jefferson City, MO
Click here to add this to my saved trials
1546
mi
from 91732
Jonesboro, AR
Click here to add this to my saved trials
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
1132
mi
from 91732
Kearney, NE
Click here to add this to my saved trials
840
mi
from 91732
Kennewick, WA
Click here to add this to my saved trials
2448
mi
from 91732
Lake Success, NY
Click here to add this to my saved trials
2313
mi
from 91732
Lancaster, PA
Click here to add this to my saved trials
2387
mi
from 91732
Langhorne, PA
Click here to add this to my saved trials
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
Little Silver, New Jersey 07739
2433
mi
from 91732
Little Silver, NJ
Click here to add this to my saved trials
Loxahatchee Groves, Florida 33470
2292
mi
from 91732
Loxahatchee Groves, FL
Click here to add this to my saved trials
2175
mi
from 91732
Lynchburg, VA
Click here to add this to my saved trials
2039
mi
from 91732
Massillon, OH
Click here to add this to my saved trials
1718
mi
from 91732
Maywood, IL
Click here to add this to my saved trials
1885
mi
from 91732
Middletown, OH
Click here to add this to my saved trials
297
mi
from 91732
Modesto, CA
Click here to add this to my saved trials
1725
mi
from 91732
Muscle Shoals, AL
Click here to add this to my saved trials
Myrtle Beach, South Carolina 29572
2234
mi
from 91732
Myrtle Beach, SC
Click here to add this to my saved trials
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
1809
mi
from 91732
New Albany, IN
Click here to add this to my saved trials
2435
mi
from 91732
Nyack, NY
Click here to add this to my saved trials
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
1659
mi
from 91732
Paducah, KY
Click here to add this to my saved trials
2273
mi
from 91732
Port Saint Lucie, FL
Click here to add this to my saved trials
1516
mi
from 91732
Quincy, IL
Click here to add this to my saved trials
2291
mi
from 91732
Randallstown, MD
Click here to add this to my saved trials
2333
mi
from 91732
Reading, PA
Click here to add this to my saved trials
1663
mi
from 91732
Rockford, IL
Click here to add this to my saved trials
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
1401
mi
from 91732
Shreveport, LA
Click here to add this to my saved trials
1302
mi
from 91732
Sioux City, IA
Click here to add this to my saved trials
2401
mi
from 91732
Somerville, NJ
Click here to add this to my saved trials
1798
mi
from 91732
South Bend, IN
Click here to add this to my saved trials
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
1400
mi
from 91732
Springfield, MO
Click here to add this to my saved trials
2306
mi
from 91732
Tamarac, FL
Click here to add this to my saved trials
2300
mi
from 91732
Towson, MD
Click here to add this to my saved trials
2364
mi
from 91732
Upland, PA
Click here to add this to my saved trials
1501
mi
from 91732
Waterloo, IA
Click here to add this to my saved trials
West Reading, Pennsylvania 19611
2332
mi
from 91732
West Reading, PA
Click here to add this to my saved trials
Willow Grove, Pennsylvania 19090
2376
mi
from 91732
Willow Grove, PA
Click here to add this to my saved trials
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials